Skip to content

Now Enrolling: LEGION-100 Phase 2 Trial for Metastatic Castration-Resistant Prostate Cancer. Find A Location Near You ›

Home
Science
Trials
About
Newsroom
Contact

Day: June 17, 2026

Syncromune® Presents Multi-Modal Efficacy Assessment Framework at Inaugural Gustave Roussy Intratumoral Immunotherapy Symposium

Posted June 17, 2026

Expanded Access

Board of Directors

Scientific Advisory Board

Syncromune® © 2026 · Terms of Use | Privacy | Cookies

*Please note the translation function may not be accurate for every dialect

Expanded Access

Board of Directors

Scientific Advisory Board

Clinical Trials

SEARCH SITE

2919 E. Commercial Blvd.
Fort Lauderdale, FL 33308

info@syncromune.com

Insert/edit link

Enter the destination URL

URL

Link Text

Open link in a new tab

Or link to existing content

Search

No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.